• High Purity 99% Cancer Treatment Afatinib API Bibw2992 CAS 439081-18-2
  • High Purity 99% Cancer Treatment Afatinib API Bibw2992 CAS 439081-18-2
  • High Purity 99% Cancer Treatment Afatinib API Bibw2992 CAS 439081-18-2
  • High Purity 99% Cancer Treatment Afatinib API Bibw2992 CAS 439081-18-2
  • High Purity 99% Cancer Treatment Afatinib API Bibw2992 CAS 439081-18-2
  • High Purity 99% Cancer Treatment Afatinib API Bibw2992 CAS 439081-18-2

High Purity 99% Cancer Treatment Afatinib API Bibw2992 CAS 439081-18-2

Powder: Yes
Customized: Customized
Certification: GMP, HSE, ISO 9001, USP, BP
Suitable for: Elderly, Children, Adult
State: Powder
Purity: >99%
Samples:
US$ 30/BAG 1 BAG(Min.Order)
| Request Sample
Customization:
Diamond Member Since 2023

Suppliers with verified business licenses

Manufacturer/Factory
  • Overview
  • Product Description
  • Product Specificaiton
  • Function & Application
  • OEM Service
  • Recommend products
  • Packaging & Shipping
  • Company Profile
  • FAQ
Overview

Basic Info.

Model NO.
HZ-Afatinib
Grade
Healethcare Products
CAS No.
439081-18-2
Appearance
White Crystal Powder
Molecular Formula
C24h25clfn5o3
Assay
99%
Test Method
HPLC
Molrcular Weight
485.94
Application
Cancer Treatment
Shelf Life
2 Years
OEM
Customization Label and Packing Bottles
Transport Package
Bottle and Carton
Specification
500mg/capsule
Trademark
Customzied
Origin
China
HS Code
29349990
Production Capacity
5000kg/Month

Product Description

Product Description

Afatinib is the first approved irreversible ErbB series blocker. The ErbB receptor family consists of 4 members: EGFR (ErbB1), HER2 (ErbB2), ErbB3 and ErbB4. ErbB family members communicate with other ErbB family members, and abnormal ErbB family signaling is a key driver of cancer cell growth and spread. Afatinib has two targets, EGFR and HER2, which can irreversibly block the mutation of epidermal growth receptor (EGFR) and the excessive performance of human epidermal receptor 2 (HER2) tyrosine kinase and stimulate abnormal internal information conduction in cells, permanently close the signaling channels on which cancer cells live, so that cancer cells cannot grow and reproduce, thereby treating cancer.

High Purity 99% Cancer Treatment Afatinib API Bibw2992 CAS 439081-18-2
High Purity 99% Cancer Treatment Afatinib API Bibw2992 CAS 439081-18-2

 

Product Specificaiton

Product Name: Afatinib Assay:  99% 
Standard Enterprise standard Appearance: White Crystalline Powder
CAS NO 439081-18-2 EINECS 1308068-626-2
Minimum  order  quantity 500g Packing: 1kg/aluminum foil bag; 25kg/drum
Item Requirements Test Results
Description Off-white powder Off-white powder
Identification HPLC ,NMR Complies
Residue on Ignition ≤0.10% 0.05%
Loss on Drying ≤0.50% 0.15%
Heavy Metal ≤20ppm <20ppm
Purity(HPLC) ≥99.0% 99.99%
Conclusion It complies with EnterpriseStandard
>Click here to get more information 
 

Function & Application

Function:
Afatinib is a drug approved for the treatment non-small cell lung carcinoma(NSCLC), developed by Boehringer Ingelheim.It acts as a angiokinase inhibitor.Like lapatinib and neratinib, afatinib is a tyrosine kinase inhibitor (TKI) that also irreversibly inhibits human epidermal growth fector receptor 2 (Her2) and epidermal growth fector receptor (EGFR) kinases. Afatinib is not only active against EGFR mutations targeted by first generation TKIs likeerlotinib or gefitinib, but also against those not sensitive to these standard therapies. Because of its additional activity against Her2, it is being investigated for breast cancer as well as other EGFR and Her2 driven cancers.
High Purity 99% Cancer Treatment Afatinib API Bibw2992 CAS 439081-18-2Application:
1. Like lapatinib and neratinib, afatinib is a protein kinase inhibitor that also irreversibly inhibits human epidermal growth fector receptor 2 (Her2) and epidermal growth fector receptor (EGFR) kinases.
2. Afatinib is not only active against EGFR mutations targeted by first generation TKIs like erlotinib or gefitinib, but also against mutations such as T790M which are not sensitive to these standard therapies.Because of its additional activity against Her2, it is being investigated for breast cancer as well as other EGFR and Her2 driven cancers.
3. Afatinib is a drug for the first-line treatment of patients with distinct types of metastatic (EGFR mutation positive) non-small cell lung carcinoma (NSCLC).It acts as an irreversible covalent inhibitor of the receptor tyrosine kinases epidermal growth fector receptor (EGFR) and erbB-2 (HER2).

OEM Service

As a professional health product supplier, we can customize Afatinib powder with different packing, Afatinib capusel with different bottles according to your formula and requests.

High Purity 99% Cancer Treatment Afatinib API Bibw2992 CAS 439081-18-2
High Purity 99% Cancer Treatment Afatinib API Bibw2992 CAS 439081-18-2

High Purity 99% Cancer Treatment Afatinib API Bibw2992 CAS 439081-18-2High Purity 99% Cancer Treatment Afatinib API Bibw2992 CAS 439081-18-2High Purity 99% Cancer Treatment Afatinib API Bibw2992 CAS 439081-18-2
High Purity 99% Cancer Treatment Afatinib API Bibw2992 CAS 439081-18-2                                                                   >Click here to get more information 

Recommend products

Fladrafinil ≥98.0% HPLC 90212-80-9
Picamilon (Sodium) ≥98%~101%Titration 62936-56-5
Sunifiram ≥99.5% HPLC 314728-85-3
Unifiram ≥99.0% HPLC 272786-64-8
Tianeptine acid ≥99.0% HPLC 66981-73-5
Tianeptine sodium ≥99.0% HPLC 30123-17-2
Tianeptine Hemisukfate Monohydrate ≥98.0%~102.0% HPLC 66981-73-5
Galantamine Hydrobromide ≥99.0% HPLC 69353-21-5
Galanthamine ≥99.0% HPLC 357-70-0
Huperzine A  ≥1.0% and 99%  HPLC 102518-79-6
NSI-189 Freebase ≥99.0% HPLC 1270138-40-3
NSI-189 Phosphate ≥99.0% HPLC 1270138-41-4
PRL-8-53  ≥99.0% HPLC 51352-87-5
agomelatine ≥99.0% HPLC 138112-76-2
5a hydroxy laxogenin ≥99.0% HPLC 56786-63-1
Vincamine ≥99.0% HPLC 1617-90-9
Centrophenoxine ≥99.0% HPLC 3685-84-5
N-coumaroyldopamine ≥99.0% HPLC 103188-46-1
N-caffeoyldopamine ≥99.0% HPLC 103188-49-4

Packaging & Shipping

Goods weight
 
Packing
 
Shipping method
 
Lead-time
 
1-50kg
 
Below 5kg Use Foil bag;5-25kg use two layer PP bag,then into master carton or cardboard drum
 
International express
 
1~3 days after your payment
100-200kg
 
25kg/drum,use two layer PP bag,then into cardboard drum
 
Air shipping
Sea Shipping
3~5 days after your payment
Over 500kg
 
25kg/drum,use two layer PP bag,then into cardboard drum
 
Sea shipping
 
5~10 days after your payment

 

High Purity 99% Cancer Treatment Afatinib API Bibw2992 CAS 439081-18-2

Company Profile

High Purity 99% Cancer Treatment Afatinib API Bibw2992 CAS 439081-18-2High Purity 99% Cancer Treatment Afatinib API Bibw2992 CAS 439081-18-2High Purity 99% Cancer Treatment Afatinib API Bibw2992 CAS 439081-18-2

FAQ

Q1: Can I get some free sample?

A: Yes, we offer free sample to client and you only need to pay the fright.

Q2: Could you accept customzied order? 
A: Yes, we accept customized service according your requests, you can communicate with sales manager to know more details.

Q3: When the product can be delivery? 
A: We normal delivery the product within 2-4 days, the more details will inform to you by our sales manager. 

Q4: Could i get certificate of analysis (COA) about product?
A: Of course, please contact us to get it. 

 
Q5: Is there any discount?
A:Yes, we can give you discount, but it depends on your quantity.

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Diamond Member Since 2023

Suppliers with verified business licenses

Manufacturer/Factory
Registered Capital
5000000 RMB
Plant Area
>2000 square meters